HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Cancer research, treatment move toward individualized care
-
- Consider variables before imaging reconstructed breast for cancer
- Erythropoietin-stimulating agents may be linked to poorer ovarian cancer outcomes
- Improved systemic therapy goal for triple-negative breast cancer
- Quitting smoking as a predictor of impending disease Michael B. Steinberg, MD, MPH, FACP
- Laparoscopic nephrectomy for kidney cancer associated with fewer ICU admissions, shorter hospitalizations
- Men and women may have different VTE risks
- Prophylactic benefits of tamoxifen for postmenopausal women appear cost-effective
- Proton therapy with chemotherapy well-tolerated in advanced lung cancer
-
- Screening failed to affect rate of prostate cancer death in Scandinavian men
- Scaling back on lymph node dissection: time for a new standard? Debu Tripathy, MD
- Melanoma meeting rounds up a busy year in melanoma research and treatment
- Novel drug shows efficacy in basal cell carcinoma
- Equine antithymocyte globulin preferable for immunosuppressive therapy in aplastic anemia Debbie Blamble, PharmD, BCOP